PubMed HealthSearch

Biomedical subjects

N Balakrishnan

Publications and source records attributed to N Balakrishnan.

2 recordsLinked to original sources

Expression patterns of risk genes associated with three evolutionarily relevant syndromes in rhesus macaque and human brains.

Depressive disorder (DD), Alzheimer's disease (AD), and schizophrenia (SZ) are evolutionarily relevant traits that disrupt neural networks supporting affect and cognition. While genome-wide association studies have identified risk-related genes for these diseases, how the expression of these genes compare across species remains unclear. In this study, we examined the spatial and temporal expression of ~2000 disease-associated genes in human and rhesus macaque brains. Distinct cross-species signatures emerged. DD-linked genes showed broad cortical-subcortical expression in humans but were confined to subcortical regions in macaques. The divergent subset was enriched for neuron differentiation, migration, synaptic signalling, and cognition. SZ-linked genes were expressed across cortical-subcortical-cerebellar structures in humans. AD-linked genes showed postnatal cortical-hippocampal macaque expression, and broader cortical-subcortical human expression. Cross-species spatial comparisons revealed a significant negative correlation for DD genes, suggesting a broader spatial distribution of DD-related gene expression in humans, extending to distributed emotion-cognition networks, compared to affective hubs in macaques. SZ genes exhibited a similar, though non-significant, negative trend, while AD genes showed a weak, non-significant correlation, indicating an absence of systematic expression shifts. Together, evolutionary shifts in gene expression may have shaped emotional and cognitive functions in humans, and susceptibility to psychiatric and neurodegenerative disorders.

Animals

Efficacy of bi-annual administration of DEC in the control of bancroftian filariasis.

The efficacy of bi-annual administration of DEC at the dose of 6 mg/kg body weight was evaluated on the microfilaraemia prevalence, density and vector filarial infection rates. Administration of four doses (4 x 6 mg/kg) of DEC significantly (P < 0.05) reduced the microfilaria rate of the community from 6.02 per cent to 2.31 per cent, microfilaria density from 0.66 to 0.17 and infectivity rate of the vector population from 0.8 per cent to 0.39 per cent.

Animals